{"id":"W3005555374","doi":"10.1097/01.hs9.0000563932.34778.38","title":"PS1414 A PHASE 1B/2 STUDY OF SELINEXOR, CARFILZOMIB, AND DEXAMETHASONE (SKD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Carfilzomib; Internal medicine; Refractory (planetary science); Dexamethasone; Oncology; Phases of clinical research; Gastroenterology; Multiple myeloma; Lenalidomide; Adverse effect; Pharmacology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003133193,0.0002858086,0.0007348915,0.0001580305,0.00004347991,0.00001371692,0.0001137393,0.0001503752,0.0006747404],"category_scores_gemma":[0.0003878608,0.0002332854,0.00008535286,0.0003736217,0.00007225003,0.00009969294,0.0001135307,0.0003860798,0.0001137421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001145935,"about_ca_system_score_gemma":0.0001489945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00108035,"about_ca_topic_score_gemma":0.001172362,"domain_scores_codex":[0.9977725,0.0001612745,0.0005053141,0.0005530216,0.0005358947,0.0004720568],"domain_scores_gemma":[0.9984003,0.0003702491,0.0001421756,0.0006329064,0.0001389726,0.0003154459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003846123,0.01329214,0.9162573,0.0004130705,0.0003569132,0.0006340999,0.002093516,0.000008882732,0.0195078,0.00001115743,0.0002716094,0.04330744],"study_design_scores_gemma":[0.2562304,0.01582117,0.6924486,0.0007349451,0.000300903,0.0001514816,0.0126525,0.006854496,0.01123336,0.00004537081,0.002863933,0.0006628316],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994121,0.001793534,0.000007965105,0.00006961879,0.00007725014,0.002121269,0.00002735619,0.00004837052,0.001733704],"genre_scores_gemma":[0.9965364,0.00008902177,0.001201216,0.00004741146,0.00005438057,0.00009369149,0.0000319316,0.00005067005,0.001895278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2523843,"threshold_uncertainty_score":0.9513105,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02940570002004456,"score_gpt":0.328572253292662,"score_spread":0.2991665532726175,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}